Beta Bionics, Inc. (BBNX) Gross Margin (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Gross Margin data on file, last reported at 59.5% in Q1 2026.

• Quarterly Gross Margin rose 864.0% year-over-year to 59.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 57.15% (up 322.0% YoY) and the FY2025 annual result came in at 55.4%, up 29.0% from the prior year.
• Gross Margin rose to 59.5% in Q1 2026 per BBNX's latest filing, from 58.98% in the prior quarter.
• The five-year high for Gross Margin was 59.5% in Q1 2026, with the low at 50.86% in Q1 2025.
• Average Gross Margin over 3 years is 55.4%, with a median of 55.48% recorded in 2025.
• Year-over-year, Gross Margin slumped 482 bps in 2025 and jumped 864 bps in 2026.
• Beta Bionics' Gross Margin stood at 57.19% in 2024, then rose by 3 bps to 58.98% in 2025, then climbed by 1 bps to 59.5% in 2026.
• Business Quant data shows BBNX's Gross Margin at 59.5% in Q1 2026, 58.98% in Q4 2025, and 55.48% in Q3 2025.